Global Ovarian Cancer Drugs Market – Industry Analysis and Forecast (2018-2026)
Global ovarian cancer drugs market was valued US$ 1.2 Bn in 2017 and is expected to reach US$ 4.6 Bn by 2026, at a CAGR of 18.29 % during a forecast period.
Ovarian Cancer begins in the female organs and that produce eggs i.e. ovaries. Ovarian cancer generally has no specific symptoms in the early stages. Later stages are associated with symptoms, but they can be non-specific such as loss of appetite and weight loss, thus the occurrence of ovarian cancer is increased.
The growing geriatric population of women, increase in ovarian cancer cases, and ease of use of new drugs and therapies, the rise in healthcare expenditure are expected to boost the growth of ovarian cancer drugs market. Increased government funding is also propelling the growth of the market. The lack of accurate diagnostic techniques for ovarian cancer in the early stages can also have a negative impact on the global ovarian cancer market.
REQUEST FOR FREE SAMPLE REPORT: https://www.maximizemarketresearch.com/request-sample/23883
Carboplatin is leading the market in chemotherapy drugs due to it is more used in developing the region. Carboplatin has much less serious side effects. Carboplatin is a chemotherapy medication used to treat a number of forms of cancer includes ovarian cancer, lung cancer, head and neck cancer, brain cancer, and neuroblastoma. It is used through injection into a vein. Some common side effects of carboplatin contain nausea, vomiting, numbness and tingling of extremities, ear infection, pain, weakness, allergic reactions, and hair loss.
North America is leading the market owing to the growing incidence of ovarian cancer in the region. The growing population of elderly women (55-64 years) is leading the growth of the North America region in ovarian cancer drugs market. In the Asia Pacific, India and China are the fastest developing countries owing to the growing healthcare expenditure in these regions, along with rising government funding and increasing target patient pool.
Key player operating in the global ovarian cancer drugs market are Bristol Myers Squibb Company, Eli Lilly and Company, GlaxosmithklinePlc, Janssen Pharmaceuticals, Inc., Kazia Therapeutics Ltd, Genentech Inc., Astra Zeneca Boehringer Ingelheim, and F. Hoffman-La Roche Ltd, among others.
The report covers a comprehensive study of major market drivers, restrains, opportunities, challenges, PESTEL, Porters, SWOT, and technological forecasting in the market.
DO INQUIRY BEFORE PURCHASING REPORT HERE: https://www.maximizemarketresearch.com/inquiry-before-buying/23883
The Scope of Global Ovarian Cancer Drugs Market:
Global Ovarian Cancer Drugs Market, by Chemotherapy Drugs:
• Carboplatin
• Cisplatin
• Docetaxel
• Paclitaxel
• Other
Global Ovarian Cancer Drugs Market, by End User:
• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Other End Users
Global Ovarian Cancer Drugs Market, by Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa
Key Player Operating In the Global Ovarian Cancer Drugs Market:
• Bristol Myers Squibb Company
• Eli Lilly and Company
• GlaxosmithklinePlc
• Janssen Pharmaceuticals, Inc.
• Kazia Therapeutics Ltd
• Genentech Inc.
• Astra Zeneca Boehringer Ingelheim
• F. Hoffman-La Roche Ltd
MAJOR TOC OF THE REPORT
Chapter One: Ovarian Cancer Drugs Market Overview
Chapter Two: Manufacturers Profiles
Chapter Three: Global Ovarian Cancer Drugs Market Competition, by Players
Chapter Four: Global Ovarian Cancer Drugs Market Size by Regions
Chapter Five: North America Ovarian Cancer Drugs Revenue by Countries
Chapter Six: Europe Ovarian Cancer Drugs Revenue by Countries
Chapter Seven: Asia-Pacific Ovarian Cancer Drugs Revenue by Countries
Chapter Eight: South America Ovarian Cancer Drugs Revenue by Countries
Chapter Nine: Middle East and Africa Revenue Ovarian Cancer Drugs by Countries
Chapter Ten: Global Ovarian Cancer Drugs Market Segment by Type
Chapter Eleven: Global Ovarian Cancer Drugs Market Segment by Application
Chapter Twelve: Global Ovarian Cancer Drugs Market Size Forecast (2019-2026)
Browse Full Report with Facts and Figures of Ovarian Cancer Drugs Market Report at: https://www.maximizemarketresearch.com/market-report/global-ovarian-cancer-drugs-market/23883/
About Us:
Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Contact info:
Name: Lumawant Godage
Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.
Email: [email protected]
Contact: +919607065656/ +919607195908
Website: www.maximizemarketresearch.com
